67513-35-3Relevant academic research and scientific papers
TARGETED COVALENT PROBES AND INHIBITORS OF PROTEINS CONTAINING REDOX-SENSITIVE CYSTEINES
-
Sheet 23, (2014/06/24)
Covalent, irreversible small-molecule inhibitors that modify the sulfenyl form (i.e., sulfenic acid, RSOH and sulfenamide, RSNR'2) of therapeutically important proteins (particularly kinases and phosphatases) are disclosed, where the compositions include a compound having a substituted aryl or heterocyclic core structure that promotes binding interactions with a specific protein, and a nucleophilic reaction center (carbon, nitrogen, sulfur, or phosphorous) that is capable of forming a covalent bond with a sulfenic acid- or sulfenamide-modified cysteine residue in the protein. Methods for synthesizing these compounds are also disclosed, as well as methods of using them for determining the bioactivity of a chemical composition comprising an active compound toward a specific protein and for determining the potency of an inhibitor against a specific protein.
Simple route to azabicyclic peroxides from tetramic acid derivatives using manganese(III)-based molecular oxygen trapping reaction
Chowdhury, Firoz Alam,Nishino, Hiroshi,Kurosawa, Kazu
, p. 575 - 591 (2007/10/03)
A simple one-step synthesis of azabicyclic peroxides was achieved by the manganese(III)-mediated oxidative formal [2+2+2] cycloaddition. The reaction of alkenes (1) with pyrrolidinediones (2) was carried out with manganese(III) acetate in acetic acid at 2
Design and implementation of an efficient synthetic approach to furanosylated indolocarbazoles: Total synthesis of (+)- and (-)-K252a
Wood, John L.,Stoltz, Brian M.,Dietrich, Hans-Jürgen,Pflum, Derek A.,Petsch, Dejah T.
, p. 9641 - 9651 (2007/10/03)
The first total synthesis of the natural product (+)-K252a (2) has been achieved in 12 steps from commercially available materials, with a longest linear sequence of seven steps and an overall yield of 21%. The synthetic strategy employs novel rhodium carbenoid chemistry in the construction of both the indolocarbazole aglycon (4) and the carbohydrate moiety (9).
